Reference:
[1] Santoro D. (2019) Therapies in Canine Atopic Dermatitis: An Update. Veterinary Clinics of North America: Small Animal Practice. 49:9-26
[2] Marsella R., Segarra S., Ahrens K., Alonso C. and Ferrer L. (2020) Topical treatment with SPHINGOLIPDS amdGLYCOSAMINOGLYCANS for canine atopic dermatitis. BMC Veterinary Research. 16: 92
[3] Cerrato S., Ramio-Lluch L., Brazis P., Fondevila D., Segarra S. and Puigdemont A. (2016) Effects of sphingolipids extracts on the morphological structure andlipid profile in an in vitro model of canine skin. The veterinary journal. 212: 58-64
[4] Segarra S., Lendinez L. and Rodriguez A. (2017) Enhancement of fibroblast migration by adding nucleotides to a combination of essential fatty acids and glycosaminoglycans. Veterinary Dermatology. Abstracts ECVD-ESVD 2017: 19-20